Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Inhalative as well as Intravenous Administration of HS Provides Neuroprotection after Ischemia and Reperfusion Injury in the Rats’ Retina.

< BACK TO ARCHIVE


2022 May 15


Int J Mol Sci


http://www.ncbi.nlm.nih.gov/pubmed/35628328?dopt=Abstract


23


10

Inhalative as well as Intravenous Administration of HS Provides Neuroprotection after Ischemia and Reperfusion Injury in the Rats’ Retina.

Authors

Inhalative as well as Intravenous Administration of HS Provides Neuroprotection after Ischemia and Reperfusion Injury in the Rats' Retina.
Scheid S, Goeller M, Baar W, Wollborn J, Buerkle H, Schlunck G, Lagrèze W, Goebel U, Ulbrich F
Int J Mol Sci. 2022 May 15; 23(10).
PMID: 35628328.

Abstract

Neuronal ischemia-reperfusion injury (IRI), such as it can occur in glaucoma or strokes, is associated with neuronal cell death and irreversible loss of function of the affected tissue. Hydrogen sulfide (HS) is considered a potentially neuroprotective substance, but the most effective route of application and the underlying mechanism remain to be determined.
Read This Paper